Evidence map›Paper›PMID 10079254›Full record

ArticleThe American journal of pathology1999

Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins.

E Kulig, L Jin, X Qian, E Horvath, K Kovacs, L Stefaneanu, B W Scheithauer, R V Lloyd

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. The hallmarks of cancer… in pituitary tumors?Reviews in endocrine & metabolic disorders · 2023
    Review
  3. Architects of Pituitary Tumour Growth.Frontiers in endocrinology · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. MicroRNAs in Human Pituitary Adenomas.International journal of endocrinology · 2014
    Review
  9. Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

E KuligDepartment of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
L Jin
X Qian
E Horvath
K Kovacs
L Stefaneanu
B W Scheithauer
R V Lloyd
Mayo Clinic · USSt. Michael's Hospital · CAUniversity of Toronto · CA

Funding

STUDIES OF NORMAL AND NEOPLASTIC HUMAN PITUITARY TISSUER01CA042951 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LLOYD, RICARDO VINCENT · 1986 to 1997
–
NCI NIH HHS CA42951
6 · The paper itself

Abstract

Analyses of apoptosis and of the apoptosis regulatory proteins Bcl-2, Bax, Bcl-X, and Bad were done in 95 nontumorous and neoplastic pituitary tissues by terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL), immunohistochemistry, and Western blotting. The apoptotic index was relatively low in all groups but was at least fourfold higher in pituitary carcinomas compared with any other groups. Pituitaries from pregnant and postpartum women had a fivefold higher apoptotic index compared with matched controls from nonpregnant females. Preoperative treatment of adenomas with octreotide or dopamine agonists did not change the apoptotic index significantly. The lowest levels of Bcl-2, Bax, and Bcl-X expression were in pituitary carcinomas as detected by immunostaining. An immortalized human pituitary adenoma cell line, HP75, developed in our laboratory using a replication-defective recombinant human adenovirus with an early large T-antigen, had a much higher level of apoptosis than nontumorous and neoplastic pituitaries. Treatment with transforming growth factor (TGF)-beta1 and protein kinase C (PKC) inhibitors increased apoptosis in this cell line. Analysis of the Bcl-2 family of proteins after treatment with TGF-beta1 and PKC inhibitors showed a 20% to 30% decrease in Bcl-X in the treated groups compared with controls. These results, which represent the first study of apoptosis in pituitaries from pregnant and postpartum cases and in pituitary carcinomas, indicate that 1) the apoptotic rate is low in nontumorous and neoplastic pituitary tissues but is relatively higher in pituitary carcinomas, 2) there are alterations in the expression of the Bcl-2 family of proteins in pituitary neoplasms with a decrease in Bcl-2 expression in pituitary carcinomas that may contribute to pituitary tumor pathogenesis and/or proliferation, and 3) cultured pituitary tumor cells respond to TGF-beta1 and PKC inhibitors by undergoing apoptotic cell death.

Indexed as

AdultApoptosisBlotting, WesternFemaleHumansImmunohistochemistryIn Situ Nick-End LabelingPituitary GlandPituitary NeoplasmsPostpartum PeriodPregnancyPregnancy Complications, NeoplasticProto-Oncogene Proteins c-bcl-2Reference ValuesTumor Cells, CulturedProto-Oncogene Proteins c-bcl-2

Identifiers

PMID10079254
PMCPMC1866431
OpenAlexW1778706801

What OpenQuestion holds

Texttitle and abstract
measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.